# Remdesivir- Ivermectin Combination Therapy in Severe Covid-19

> **NCT04944082** · PHASE4 · UNKNOWN · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT04944082
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04944082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04944082, "Remdesivir- Ivermectin Combination Therapy in Severe Covid-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04944082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*